Top UDR (NYSE: UDR) executive Fisher exits with $6.0M severance deal
Rhea-AI Filing Summary
UDR, Inc. reported that Joseph D. Fisher resigned as President and Chief Investment Officer effective at the close of business on September 2, 2025. The Board named Chairman and CEO Thomas W. Toomey as President, with Fisher’s responsibilities shared by Toomey and other executives.
Under a separation agreement dated September 2, 2025, Fisher will receive a $3.0 million severance payment and may receive an additional $3.0 million over 12 months if he complies with non-solicitation, confidentiality, non-disparagement, and other terms. The agreement allows the company to claw back 50% of contingent severance already paid if he materially breaches it.
Fisher will receive continued group health insurance benefits through September 30, 2030 under certain conditions. The agreement includes a general release of claims, a non-solicitation covenant lasting until September 1, 2026, and mutual non-disparagement. Covenants become effective September 11, 2025, and Fisher may revoke the agreement until September 9, 2025. He has agreed to provide transition assistance through December 31, 2025.
Positive
- None.
Negative
- Leadership change in key investment role: The resignation of the President and Chief Investment Officer, with the CEO assuming the President title, may raise concerns about succession planning and potential disruption in investment oversight.
Insights
Senior investment executive exits; CEO adds President role and company grants sizable, conditioned severance.
The departure of UDR, Inc.’s President and Chief Investment Officer, Joseph D. Fisher, effective September 2, 2025, removes a key leader overseeing investments. The Board has consolidated leadership by appointing Chairman and CEO Thomas W. Toomey as President, while other managers assume Fisher’s duties.
The separation agreement grants a $3.0 million lump-sum severance plus up to $3.0 million in contingent severance over 12 months, tied to compliance with non-solicitation, confidentiality, and non-disparagement covenants. A clawback of 50% of contingent amounts applies if he breaches material terms, partly protecting the company.
Fisher’s continued health benefits through September 30, 2030, his agreement to provide transition assistance through December 31, 2025, and the non-solicitation covenant through September 1, 2026 aim to support organizational stability and limit competitive impact. Future disclosures in company filings may describe any further leadership or organizational changes.